Flamingo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 6.80 Cr
as on 08-07-2024
- Company Age 39 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 138.87 Cr
as on 08-07-2024
- Satisfied Charges ₹ 432.45 Cr
as on 08-07-2024
- Revenue -1.28%
(FY 2022)
- Profit -58.24%
(FY 2022)
- Ebitda -27.09%
(FY 2022)
- Net Worth 2.38%
(FY 2022)
- Total Assets 1.40%
(FY 2022)
About Flamingo Pharmaceuticals
The Corporate was formerly known as Flamingo Impex Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.80 Cr.
The company currently has active open charges totaling ₹138.87 Cr. The company has closed loans amounting to ₹432.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Flamingo Pharmaceuticals Limited India are Sunil Kumar as CEO and Sukrut Shah as Cfo. Ashwin Thacker, Pranay Thacker, Chhotulal Bhagwat, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51900MH1985PLC036572
- Company No.
036572
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Jun 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Flamingo Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Kumar | CEO | Current | |
| Sukrut Shah | CFO | 17-Aug-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chhotulal Bhagwat  | Director | 25-Oct-2022 | Current |
| Ashwin Thacker | Director | 23-Jun-1986 | Current |
| Pranay Thacker | Director | 08-Jun-2021 | Current |
| Meena Kapadi | Director | 28-Sep-2022 | Current |
| Parth Thacker | Additional Director | Current |
Financial Performance and Corporate Structure Insights of Flamingo Pharmaceuticals.
Flamingo Pharmaceuticals Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.28% decrease. The company also saw a substantial fall in profitability, with a 58.24% decrease in profit. The company's net worth moved up by a moderate rise of 2.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Flamingo Pharmaceuticals?
In 2021, Flamingo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prime Property Development Corporation LimitedActive 31 years 11 monthsMeena Kapadi is a mutual person
Flamingo Healthcare LimitedActive 16 years 8 monthsAshwin Thacker, Pranay Thacker and 1 more are mutual person
- Mini Med Laboratories Pvt LtdActive 31 years 10 months
Ashwin Thacker, Pranay Thacker and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Feb 2023 | ₹2.20 M | Open |
Others Creation Date: 18 Nov 2022 | ₹18.15 Cr | Open |
Others Creation Date: 22 Feb 2022 | ₹20.00 Cr | Open |
How Many Employees Work at Flamingo Pharmaceuticals?
Flamingo Pharmaceuticals has a workforce of 552 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Flamingo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flamingo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
